FDA Rethinks Its Strategy on Future COVID Vaccines
January 25, 2023
(Axios) – An FDA advisory panel meeting tomorrow could start a reset of how the U.S. approaches its COVID-19 vaccine strategy. Driving the news: The agency has sent signs they want to move from the on-the-fly response that’s, at times, left the public confused to an annual vaccination schedule that more closely mirrors flu vaccines. (Read More)